← Leaderboards
Vincent Crowley
University Of Kansas Lawrence
$379,204
Attributed
$379,204
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $85.4K · FY2016–21$100K$75K$50K$25K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$379,204 · 2
By mechanism
K00$316,058 · 1
F99$63,146 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Mark Steven Cohen$1,514,123
- Heng Du$7,572,954
- Heather R Desaire$14,470,184
- Mary L. Michaelis$8,095,023
- Rick T Dobrowsky$8,170,709
Others in their field
Top investigators on “Communication”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$579,784,705
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Judith S. Currier · University Of California Los Angeles$275,255,726
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$254,611,637
- Lawrence Corey · Fred Hutchinson Cancer Center$237,586,227
Research focus
CommunicationAffinityAdhesionsColorectalApoptosisAreaBaseAffectBinding SitesAnti-Cancer TherapeuticBreast Cancer Cell LineCancer EtiologyCancer TherapyCancer TypeCareerCell MotilityCell ProliferationCell SurvivalCessation Of LifeChemistryClientBiologyClinical TrialsCyclophilin D
Grant awards (6)
The Development of Organelle Specific Hsp90 Isoform-Selective Inhibitors$85,399
K00 · FY2021 · CA · contact PI
The Development of Organelle Specific Hsp90 Isoform-Selective Inhibitors$80,873
K00 · FY2020 · CA · contact PI
The Development of Organelle Specific Hsp90 Isoform-Selective Inhibitors$76,346
K00 · FY2019 · CA · contact PI
The Development of Organelle Specific Hsp90 Isoform-Selective Inhibitors$73,440
K00 · FY2018 · CA · contact PI
The Development of Organelle Specific Hsp90 Isoform-Selective Inhibitors$30,744
F99 · FY2017 · CA · contact PI
The Development of Organelle Specific Hsp90 Isoform-Selective Inhibitors$32,402
F99 · FY2016 · CA · contact PI